Chemours Company FC, LLC v. Daikin Industries, Ltd.

CourtDistrict Court, D. Delaware
DecidedJanuary 13, 2022
Docket1:17-cv-01612
StatusUnknown

This text of Chemours Company FC, LLC v. Daikin Industries, Ltd. (Chemours Company FC, LLC v. Daikin Industries, Ltd.) is published on Counsel Stack Legal Research, covering District Court, D. Delaware primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Chemours Company FC, LLC v. Daikin Industries, Ltd., (D. Del. 2022).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE

CHEMOURS COMPANY FC, LLC, ) ) Plaintiff, ) ) v. ) Civil Action No. 17-1612-MN-CJB ) DAIKIN INDUSTRIES, LTD. and ) DAIKIN AMERICA, INC., ) ) Defendants. )

REPORT AND RECOMMENDATION In this action filed by Plaintiff Chemours Company FC, LLC (“Chemours” or “Plaintiff”) against Defendants Daikin Industries, Ltd. and Daikin America, Inc. (“Daikin” or “Defendants”), Chemours alleges infringement of United States Patent Nos. 7,122,609 (the “'609 patent”) and 8,076,431 (the “'431 patent” and collectively with the '609 patent, “the asserted patents” or the “patents-in-suit”). Presently before the Court is the matter of claim construction. (D.I. 179; D.I. 184) The Court recommends that the District Court adopt the constructions set forth below. I. BACKGROUND Chemours commenced this action on November 8, 2017. (D.I. 1) On December 21, 2018, the case was stayed pending completion of inter partes review (“IPR”) proceedings involving the asserted patents. (See D.I. 77 at 32-33) On November 12, 2019, the United States Patent and Trademark Office’s Patent Trial and Appeal Board (“PTAB”) issued two Final Written Decisions finding all claims of both asserted patents unpatentable. (See D.I. 80 at 2) Chemours appealed these decisions, and on July 22, 2021, the United States Court of Appeals for the Federal Circuit reversed the PTAB’s unpatentability decisions. (Id.); see also Chemours Co. FC, LLC v. Daikin Indus., Ltd., 4 F.4th 1370 (Fed. Cir. 2021). On August 3, 2021, the District Court lifted the stay of the case. (D.I. 81) The case was thereafter referred to the Court by United States District Judge Maryellen Noreika to hear and resolve all pretrial matters up to and including expert discovery matters. (D.I. 98) A trial is set to begin on July 11, 2022. (D.I. 87 at ¶ 20)

The asserted patents are directed to specific fluorinated ethylene propylene (“FEP”) polymer compositions that are used to insulate communications cables. (See D.I. 153 at 1, 3) Both patents are entitled “High Melt Flow Fluoropolymer,” and they claim priority to an application filed on May 14, 2003. (D.I. 158, exs. 1-2)1 The specification explains that prior to the invention, there was a need for FEPs capable of being extruded at high speeds while still producing a high quality wire coating. ('609 patent, col. 1:10-49) The inventors of the asserted patents created an FEP that can be processed at high speeds and over a broad range of operating conditions. (Id., Abstract; id., col. 1:53-62) The claimed FEP has: (1) a minimal concentration of alkali metal salt; (2) a high melt flow rate; and (3) a low number of unstable end groups. (Id.; see also D.I. 153 at 1)

Chemours alleges that Daikin’s copolymers, including Neoflon® FEP NP-1108, Neoflon FEP NP-1109 and Neoflon FEP NP-3180, infringe certain claims of the asserted patents. (D.I. 13 at ¶¶ 35, 51) Further details regarding the asserted patents will be provided below in Section III. On October 15, 2021, the parties filed their joint claim construction brief. (D.I. 153) Both parties subsequently submitted Notices of Supplemental Evidence in support of their claim

1 The asserted patents appear on the docket in this action more than once. The two patents-in-suit share the same specification. (See D.I. 153 at 3) Further citations will simply be to the '609 patent, and all citations to the patent specification will be to the '609 patent unless otherwise indicated. 2 construction decisions, which relate to depositions taken after submission of the joint claim construction brief. (D.I. 197; D.I. 213) The Court conducted a Markman hearing on November 16, 2021. (D.I. 246 (hereinafter, “Tr.”)) In December 2021, Daikin submitted a Notice of Supplemental Authority in support of its claim construction positions. (D.I. 241)

II. STANDARD OF REVIEW The Court has often set out the relevant legal standard for claim construction, including in Vytacera Bio LLC v. CytomX Therapeutics, Inc., Civil Action No. 20-333-LPS-CJB, 2021 WL 4621866, at *2-3 (D. Del. Oct. 7, 2021). The Court hereby incorporates by reference its discussion in Vytacera Bio of these legal standards and will follow them herein. To the extent consideration of the disputed terms here necessitates discussion of other, related legal principles, the Court will discuss those principles in Section III below. III. DISCUSSION The parties set out three disputed terms or sets of terms (hereinafter, “terms”) for the Court’s review. The Court takes up the terms in the order in which they were argued.

A. “melt flow rate” The first disputed term, “melt flow rate” (also referred to as “MFR” below), appears, inter alia, in claims 1 and 2 of the '609 patent and claims 3 and 4 (as depending from claim 1) of the '431 patent. The parties’ competing proposed constructions for “melt flow rate” are set out in the chart below: Term Plaintiff’s Proposed Defendants’ Proposed Construction Construction “melt flow rate” Plain and ordinary meaning, “the rate of extrusion of which is “the amount of mass molten resins through a die of or volume of a viscous specified length and diameter material moving past a under prescribed conditions of temperature, load, and 3 reference point as a function piston position in the barrel as of time” the timed measurement is being made, in accordance with ASTM D-1238 and ASTM D-2116”

(D.I. 153 at 32-33) The parties’ dispute with respect to this term is whether it should be construed to require measurements made in accordance with specific industry standards (i.e., ASTM D-1238 and ASTM D-2116, or the “ASTM standards”). (See id. at 35-36; Tr. at 11, 14) Chemours argues that it is not necessary to import into the claims various limitations relating to testing methods set out in the ASTM standards; Daikin asserts that the proper construction of “melt flow rate” requires reference to such standards. (D.I. 153 at 35-36, 47; Tr. at 11) For the following reasons, the Court concludes that the plain and ordinary meaning of “melt flow rate” does not align with Daikin’s proposed construction. As an initial matter, in order to determine the correct answer here, it is important to first understand what these ASTM standards actually are. It is undisputed that ASTM D-1238 is a test method that is used measure melt flow rate. (D.I. 153 at 34-35; D.I. 155, ex. 28 at DKN0001130; Tr. at 17, 48) It is also undisputed that the specification of the asserted patents states that “[t]he melt flow rates (MFR) of FEP copolymers are determined in accordance with ASTM D1238[.]” ('609 patent, col. 2:38-39; see also D.I. 153 at 34-36; see also Tr. at 62 (Chemours’ counsel acknowledging that “I agree that [the] person skilled in the art reading the patent in [light of] the specification understands that [the] melt flow rate is determined using the ASTM standard”))2

2 The ASTM D-2116 standard defines FEPs and states that the melt flow rate is determined by the test method described in ASTM D-1238. (D.I. 155, ex. 29 at ¶¶ 1.1, 11.1.1) The ASTM D-2116 standard is not mentioned in the patents. (See D.I. 153 at 35)

4 Understanding this then, and absent strong evidence in the record to the contrary, it does not seem right to say that a test method used to measure a property (i.e., “melt flow rate”) would amount to the plain and ordinary meaning of the property itself. (D.I. 153 at 35; Tr. at 18, 26-27) Chemours agrees, and asserts that a person of ordinary skill in the art (“POSITA”) would instead

understand the plain and ordinary meaning of “melt flow rate” to be simply “the amount of mass or volume of a viscous material . . . [moving] past a reference point as a function of time.” (D.I. 153 at 33-34 (citing D.I. 158, ex. 8 at ¶ 26))3 Turning next to the intrinsic record, the claims’ language provides support for Chemours’ proposed construction.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Merck & Co. v. Teva Pharmaceuticals USA, Inc.
395 F.3d 1364 (Federal Circuit, 2005)
Ppg Industries v. Guardian Industries Corp.
156 F.3d 1351 (Federal Circuit, 1998)
Key Pharmaceuticals v. Hercon Laboratories Corporation
161 F.3d 709 (Federal Circuit, 1999)
The Toro Company, Plaintiff-Cross v. Deere & Company
355 F.3d 1313 (Federal Circuit, 2004)
Ferring B v. v. Watson Laboratories, Inc.
764 F.3d 1382 (Federal Circuit, 2014)
Biosig Instruments, Inc. v. Nautilus, Inc.
783 F.3d 1374 (Federal Circuit, 2015)
Teva Pharmaceuticals USA, Inc. v. Sandoz, Inc.
789 F.3d 1335 (Federal Circuit, 2015)
Aylus Networks, Inc. v. Apple Inc.
856 F.3d 1353 (Federal Circuit, 2017)
Baxalta Inc. v. Genentech, Inc.
972 F.3d 1341 (Federal Circuit, 2020)
Sincavage v. Barnhart
171 F. App'x 924 (Third Circuit, 2006)
Henderson v. Carlson
812 F.2d 874 (Third Circuit, 1987)

Cite This Page — Counsel Stack

Bluebook (online)
Chemours Company FC, LLC v. Daikin Industries, Ltd., Counsel Stack Legal Research, https://law.counselstack.com/opinion/chemours-company-fc-llc-v-daikin-industries-ltd-ded-2022.